Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
su.phyu@immonc.ox.ac.uk
su.phyu@oncology.ox.ac.uk

ORCID
https://orcid.org/0000-0003-1775-6966

Pronouns
She/her

Su Myat Phyu

MB,BS PhD

Postdoctoral Scientist

Recent publications

Non-cell-autonomous cancer progression from chromosomal instability.
Journal article

Li J. et al, (2023), Nature, 620, 1080 - 1088
The clinical and molecular significance associated with STING signaling in breast cancer.
Journal article

Parkes EE. et al, (2021), NPJ breast cancer, 7
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.
Journal article

Philippou Y. et al, (2020), British journal of cancer, 123, 1089 - 1100
Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporation.
Journal article

Phyu SM. and Smith TAD., (2019), Investigational new drugs, 37, 424 - 430
CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.
Journal article

Phyu SM. et al, (2019), Magma (New York, N.Y.), 32, 227 - 235

More publications